XML 50 R24.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Tables)
6 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Schedule of stockholders' equity
The changes in stockholders’ equity for the prior year comparable period is as follows:

 Common Stock
(dollars in thousands)SharesAmountAdditional
Paid-in
Capital
Accumulated
Other
Comprehensive
Loss
Accumulated
Deficit
Total
Balance at September 30, 201832,774,118  $33  $236,115  $(6,449) $(100,045) $129,654  
Cumulative adjustment related to the adoption of ASC 606—  —  —  —  730  730  
Net loss—  —  —  —  (5,022) (5,022) 
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units          409,060  —   —  —   
Stock compensation expense—  —  1,556  —  —  1,556  
Foreign currency translation—  —  —  (427) —  (427) 
Balance at December 31, 201833,183,178  $33  $237,679  $(6,876) $(104,337) $126,499  
Net loss—  —  —  —  (4,362) (4,362) 
Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units197,642  —  116  —  —  116  
Stock compensation expense—  —  2,011  —  —  2,011  
Forfeitures of restricted stock awards(33,163) —  —  —  —  —  
Foreign currency translation—  —  —  198   201  
Balance at March 31, 201933,347,657  $33  $239,806  $(6,678) $(108,696) $124,465  
Summary of stock options and restricted stock granted
The following table presents stock option and RSUs & RSAs grant activity:

Six Months Ended
March 31, 2020
Stock Options granted:
Options containing only service conditions:415,719  
Weighted average exercise price$6.82  
Weighted average grant date fair value$2.72  
Options containing performance or market conditions:402,800  
Weighted average exercise price$6.82  
Weighted average grant date fair value$2.62  
RSUs & RSAs granted:
RSUs & RSAs containing only service conditions:310,493  
Weighted average grant date fair value$5.92  
RSUs & RSAs containing performance or market conditions:173,600  
Weighted average grant date fair value$4.49